Addex Therapeutics (ADXN) Current Leases (2018 - 2026)
Addex Therapeutics (ADXN) posted Current Leases of $98637.1 for Q1 2026, up 926.51% sequentially from $9609.0 in Q4 2025, and up 1098.74% YoY from $8228.4 in Q1 2025.
Addex Therapeutics (ADXN) Current Leases (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported Current Leases for 9 years, with the latest figure at $98637.1 in Q1 2026.
- Quarterly Current Leases rose 1098.74% year-over-year to $98637.1 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98637.1 (up 1098.74% YoY) and the FY2025 annual result came in at $9263.1, up 11.54% from the prior year.
- Current Leases climbed to $98637.1 in Q1 2026 per ADXN's latest filing, from $9609.0 in the prior quarter.
- Over five years, Current Leases peaked at $316291.6 in Q1 2022 and troughed at $8228.4 in Q1 2025.
- A 5-year average of $138030.9 and a median of $98637.1 in 2026 frame the typical range for Current Leases.
- The sharpest annual moves came in 2024 and 2026: Current Leases sank 97.3% in 2024, then surged 1098.74% in 2026.
- Over 5 years, Current Leases stood at $296985.3 in 2022, then climbed by 3.99% to $308845.5 in 2023, then plunged by 97.3% to $8340.0 in 2024, then climbed by 15.22% to $9609.0 in 2025, then soared by 926.51% to $98637.1 in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $98637.1, $9609.0, and $9482.1 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | 98,637.12 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 98,637.12 |
| Dec 31, 2025 | 9,608.98 |
| Sep 30, 2025 | 9,482.08 |
| Jun 30, 2025 | 9,048.31 |
| Mar 31, 2025 | 8,228.43 |
| Dec 31, 2024 | 8,339.96 |
| Sep 30, 2024 | 8,327.61 |
| Jun 30, 2024 | 13,702.99 |
| Mar 31, 2024 | 14,022.01 |
| Dec 31, 2023 | 308,845.52 |
| Sep 30, 2023 | 233,693.27 |
| Jun 30, 2023 | 222,306.10 |
| Mar 31, 2023 | 240,867.89 |
| Dec 31, 2022 | 296,985.34 |
| Sep 30, 2022 | 296,059.83 |
| Jun 30, 2022 | 252,078.85 |
| Mar 31, 2022 | 316,291.58 |
| Dec 31, 2021 | 312,009.08 |
| Sep 30, 2021 | 316,925.68 |
| Jun 30, 2021 | 283,674.10 |